Search

Search Constraints

You searched for: Author/Creator de Langen, Adrianus J.

Search Results

1. Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses. (October 2018)

3. High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial. (August 2022)

4. High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes. Issue 2 (23rd May 2017)

5. Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges. (March 2022)

6. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations. (10th November 2020)

8. Outcomes of Hypofractionated High‐Dose Radiotherapy in Poor‐Risk Patients with "Ultracentral" Non–Small Cell Lung Cancer. Issue 7 (July 2016)